Addus HomeCare (ADUS) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

ADUS Stock Forecast


Addus HomeCare stock forecast is as follows: an average price target of $123.00 (represents a -5.48% downside from ADUS’s last price of $130.13) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

ADUS Price Target


The average price target for Addus HomeCare (ADUS) is $123.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $141.00 to $83.00. This represents a potential -5.48% downside from ADUS's last price of $130.13.

ADUS Analyst Ratings


Buy

According to 6 Wall Street analysts, Addus HomeCare's rating consensus is 'Buy'. The analyst rating breakdown for ADUS stock is 0 'Strong Buy' (0.00%), 5 'Buy' (83.33%), 0 'Hold' (0.00%), 1 'Sell' (16.67%), and 0 'Strong Sell' (0.00%).

Addus HomeCare Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 08, 2024Frank MorganRBC Capital$141.00$122.2215.37%8.35%
Aug 07, 2024Michael WiederhornOppenheimer$140.00$122.2214.55%7.58%
Jun 07, 2024Michael WiederhornOppenheimer$130.00$116.0712.00%-0.10%
May 31, 2024Scott FidelStephens$128.00$111.7314.56%-1.64%
May 28, 2024Frank MorganRBC Capital$129.00$111.6115.58%-0.87%
Apr 23, 2024Andrew MokBarclays$83.00$93.14-10.89%-36.22%
Apr 01, 2024Scott FidelStephens$115.00$103.3411.28%-11.63%
Jun 29, 2022Scott FidelStephens$101.00$85.1418.63%-22.39%
May 04, 2022-RBC Capital$111.00$82.3434.81%-14.70%
Row per page
Go to

The latest Addus HomeCare stock forecast, released on Aug 08, 2024 by Frank Morgan from RBC Capital, set a price target of $141.00, which represents a 15.37% increase from the stock price at the time of the forecast ($122.22), and a 8.35% increase from ADUS last price ($130.13).

Addus HomeCare Price Target by Period


1M3M12M
# Anlaysts-27
Avg Price Target-$140.50$123.71
Last Closing Price$130.13$130.13$130.13
Upside/Downside-100.00%7.97%-4.93%

In the current month, the average price target of Addus HomeCare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Addus HomeCare's last price of $130.13. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Sep 03, 2024StephensBuyBuyHold
Sep 03, 2024RBC CapitalUnderperformUnderperformHold
Aug 08, 2024Cowen & Co.BuyBuyHold
Aug 08, 2024RBC CapitalOutperformOutperformHold
Aug 07, 2024OppenheimerOutperformOutperformHold
Aug 07, 2024StephensOverweightOverweightHold
Aug 06, 2024OppenheimerUnderperformUnderperformHold
Aug 06, 2024StephensBuyBuyHold
Jun 28, 2024Macquarie-OutperformInitialise
Jun 18, 2024OppenheimerUnderperformUnderperformHold
Row per page
Go to

Addus HomeCare's last stock rating was published by Stephens on Sep 03, 2024. The company gave ADUS a "Buy" rating, the same as its previous rate.

Addus HomeCare Financial Forecast


Addus HomeCare Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$276.35M$270.72M$259.98M$251.60M$247.05M$240.50M-$226.63M$224.64M$216.66M$217.89M$205.30M$196.00M$193.99M$184.58M$190.22M$190.04M$169.80M
Avg Forecast$390.26M$391.38M$387.65M$375.48M$350.37M$349.09M$339.28M$331.02M$297.29M$289.62M$284.90M$279.49M$274.47M$267.15M$256.31M$250.05M$246.14M$242.20M$238.48M$227.40M$226.21M$226.34M$216.79M$209.78M$197.71M$189.16M$172.12M$177.94M$182.91M$159.89M
High Forecast$392.74M$393.87M$390.11M$377.87M$352.60M$351.31M$341.44M$333.12M$299.18M$291.75M$286.71M$281.26M$276.73M$268.85M$257.94M$251.64M$247.71M$243.74M$238.48M$230.14M$228.93M$229.07M$219.40M$212.30M$200.09M$191.43M$174.19M$180.08M$185.11M$161.81M
Low Forecast$386.68M$387.79M$384.09M$372.03M$347.15M$345.88M$336.17M$327.98M$294.56M$287.30M$282.28M$276.92M$271.94M$264.70M$253.96M$247.76M$243.88M$239.98M$238.48M$224.43M$223.26M$223.39M$213.96M$207.04M$195.13M$186.69M$169.88M$175.62M$180.52M$157.80M
# Analysts333344443633633344234564646453
Surprise %------------1.01%1.01%1.01%1.01%1.00%0.99%-1.00%0.99%0.96%1.01%0.98%0.99%1.03%1.07%1.07%1.04%1.06%

Addus HomeCare's average Quarter revenue forecast for Mar 24 based on 3 analysts is $279.49M, with a low forecast of $276.92M, and a high forecast of $281.26M. ADUS's average Quarter revenue forecast represents a 1.13% increase compared to the company's last Quarter revenue of $276.35M (Dec 23).

Addus HomeCare EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts333344443633633344234564646453
EBITDA------------$33.02M$27.04M$24.92M$22.05M$24.30M$20.96M-$17.09M$23.44M$20.80M$20.67M$15.79M$14.94M$15.65M$12.70M$13.88M$17.15M$10.25M
Avg Forecast$33.65M$33.74M$33.42M$32.37M$30.21M$30.10M$29.25M$28.54M$25.63M$24.97M$24.56M$20.41M$23.66M$23.03M$22.10M$18.55M$21.22M$23.44M$20.56M$16.87M$22.16M$21.31M$21.18M$15.79M$13.55M$13.01M$7.13M$10.80M$15.77M$9.54M
High Forecast$33.86M$33.96M$33.64M$32.58M$30.40M$30.29M$29.44M$28.72M$25.80M$25.15M$24.72M$24.49M$23.86M$23.18M$22.24M$22.26M$21.36M$28.13M$20.56M$20.24M$26.59M$25.57M$25.42M$18.95M$16.26M$15.61M$8.55M$12.96M$15.96M$11.45M
Low Forecast$33.34M$33.43M$33.12M$32.08M$29.93M$29.82M$28.98M$28.28M$25.40M$24.77M$24.34M$16.33M$23.45M$22.82M$21.90M$14.84M$21.03M$18.75M$20.56M$13.49M$17.73M$17.05M$16.95M$12.63M$10.84M$10.40M$5.70M$8.64M$15.56M$7.63M
Surprise %------------1.40%1.17%1.13%1.19%1.15%0.89%-1.01%1.06%0.98%0.98%1.00%1.10%1.20%1.78%1.29%1.09%1.07%

3 analysts predict ADUS's average Quarter EBITDA for Mar 24 to be $20.41M, with a high of $24.49M and a low of $16.33M. This is -38.19% lower than Addus HomeCare's previous annual EBITDA (Dec 23) of $33.02M.

Addus HomeCare Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts333344443633633344234564646453
Net Income------------$19.58M$15.41M$14.85M$12.68M$14.76M$11.54M-$8.47M$13.06M$11.58M$11.60M$8.89M$8.45M$9.12M$6.91M$8.66M$9.99M$4.87M
Avg Forecast$28.41M$27.18M$26.70M$23.97M$26.69M$24.70M$24.24M$22.51M$22.47M$21.44M$20.03M$10.11M$19.34M$17.87M$16.66M$9.19M$15.72M$13.05M$14.78M$8.36M$12.35M$11.86M$11.89M$8.89M$7.66M$7.58M$3.88M$6.73M$10.74M$4.53M
High Forecast$28.65M$27.40M$26.92M$24.17M$26.91M$24.91M$24.44M$22.70M$22.65M$22.10M$20.20M$12.14M$19.67M$18.01M$16.80M$11.03M$15.85M$15.65M$14.78M$10.03M$14.82M$14.23M$14.26M$10.67M$9.19M$9.09M$4.65M$8.08M$10.91M$5.44M
Low Forecast$28.08M$26.85M$26.38M$23.68M$26.37M$24.41M$23.95M$22.25M$22.20M$21.27M$19.79M$8.09M$18.67M$17.65M$16.46M$7.36M$15.53M$10.44M$14.78M$6.69M$9.88M$9.49M$9.51M$7.12M$6.13M$6.06M$3.10M$5.39M$10.56M$3.63M
Surprise %------------1.01%0.86%0.89%1.38%0.94%0.88%-1.01%1.06%0.98%0.98%1.00%1.10%1.20%1.78%1.29%0.93%1.07%

Addus HomeCare's average Quarter net income forecast for Mar 24 is $10.11M, with a range of $8.09M to $12.14M. ADUS's average Quarter net income forecast represents a -48.34% decrease compared to the company's last Quarter net income of $19.58M (Dec 23).

Addus HomeCare SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts333344443633633344234564646453
SG&A------------$60.77M$60.27M$57.40M$56.36M$54.47M$54.23M-$53.15M$49.54M$46.28M$48.17M$45.43M$44.21M$40.73M$42.45M$45.17M$41.69M$38.71M
Avg Forecast$85.37M$85.62M$84.80M$82.14M$76.65M$76.37M$74.22M$72.41M$65.03M$63.36M$62.32M$63.47M$60.04M$58.44M$56.07M$57.70M$53.85M$52.15M$52.17M$52.45M$46.84M$47.41M$49.38M$45.43M$40.08M$33.84M$23.82M$35.14M$40.01M$36.04M
High Forecast$85.92M$86.16M$85.34M$82.66M$77.13M$76.85M$74.69M$72.87M$65.45M$63.82M$62.72M$76.16M$60.54M$58.81M$56.43M$69.24M$54.19M$62.58M$52.17M$62.94M$56.21M$56.89M$59.26M$54.51M$48.10M$40.61M$28.59M$42.16M$40.49M$43.24M
Low Forecast$84.59M$84.83M$84.02M$81.39M$75.94M$75.66M$73.54M$71.75M$64.44M$62.85M$61.75M$50.77M$59.49M$57.90M$55.56M$46.16M$53.35M$41.72M$52.17M$41.96M$37.48M$37.93M$39.50M$36.34M$32.07M$27.07M$19.06M$28.11M$39.49M$28.83M
Surprise %------------1.01%1.03%1.02%0.98%1.01%1.04%-1.01%1.06%0.98%0.98%1.00%1.10%1.20%1.78%1.29%1.04%1.07%

Addus HomeCare's average Quarter SG&A projection for Mar 24 is $63.47M, based on 3 Wall Street analysts, with a range of $50.77M to $76.16M. The forecast indicates a 4.45% rise compared to ADUS last annual SG&A of $60.77M (Dec 23).

Addus HomeCare EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts333344443633633344234564646453
EPS------------$1.20$0.96$0.92$0.79$0.92$0.72-$0.54$0.82$0.73$0.73$0.56$0.53$0.58$0.44$0.56$0.64$0.31
Avg Forecast$1.72$1.65$1.62$1.45$1.62$1.50$1.47$1.36$1.36$1.30$1.21$1.11$1.17$1.08$1.01$0.88$0.95$0.92$0.90$0.75$0.91$0.89$0.87$0.74$0.73$0.64$0.48$0.60$0.66$0.57
High Forecast$1.74$1.66$1.63$1.46$1.63$1.51$1.48$1.38$1.37$1.34$1.22$1.12$1.19$1.09$1.02$0.88$0.96$0.93$0.90$0.76$0.92$0.90$0.88$0.75$0.75$0.65$0.49$0.61$0.67$0.58
Low Forecast$1.70$1.63$1.60$1.44$1.60$1.48$1.45$1.35$1.35$1.29$1.20$1.10$1.13$1.07$1.00$0.86$0.94$0.91$0.90$0.74$0.89$0.87$0.85$0.73$0.72$0.63$0.47$0.59$0.65$0.56
Surprise %------------1.02%0.89%0.91%0.90%0.97%0.78%-0.72%0.90%0.82%0.84%0.76%0.73%0.90%0.91%0.94%0.97%0.55%

According to 3 Wall Street analysts, Addus HomeCare's projected average Quarter EPS for Mar 24 is $1.11, with a low estimate of $1.10 and a high estimate of $1.12. This represents a -7.40% decrease compared to ADUS previous annual EPS of $1.20 (Dec 23).

Addus HomeCare Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
SGRYSurgery Partners$31.00$47.5053.23%Buy
AMEDAmedisys$96.91$143.3847.95%Hold
EHABEnhabit$8.10$10.2526.54%Hold
OPCHOption Care Health$31.99$38.0018.79%Buy
SEMSelect Medical$35.23$40.0013.54%Buy
INNVInnovAge$5.99$6.8013.52%Hold
ACHCAcadia Healthcare Company$78.23$84.898.51%Buy
EHCEncompass Health$93.25$93.17-0.09%Buy
ADUSAddus HomeCare$130.13$123.00-5.48%Buy
UHSUniversal Health Services$232.56$208.47-10.36%Hold
PNTGPennant Group$34.52$30.67-11.15%Buy
ENSGEnsign Group$152.73$114.25-25.19%Buy

ADUS Forecast FAQ


Yes, according to 6 Wall Street analysts, Addus HomeCare (ADUS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 83.33% of ADUS's total ratings.

Addus HomeCare (ADUS) average price target is $123 with a range of $83 to $141, implying a -5.48% from its last price of $130.13. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for ADUS stock, the company can go down by -5.48% (from the last price of $130.13 to the average price target of $123), up by 8.35% based on the highest stock price target, and down by -36.22% based on the lowest stock price target.

ADUS's average twelve months analyst stock price target of $123 does not support the claim that Addus HomeCare can reach $200 in the near future.

Addus HomeCare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.37B (high $1.38B, low $1.36B), average EBITDA is $118.1M (high $118.85M, low $117.02M), average net income is $98.15M (high $98.96M, low $96.97M), average SG&A $299.64M (high $301.55M, low $296.89M), and average EPS is $5.95 (high $6, low $5.88). ADUS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.54B (high $1.55B, low $1.53B), average EBITDA is $133.19M (high $134.04M, low $131.97M), average net income is $106.26M (high $107.14M, low $104.99M), average SG&A $337.93M (high $340.08M, low $334.83M), and average EPS is $6.44 (high $6.49, low $6.36).

Based on Addus HomeCare's last annual report (Dec 2023), the company's revenue was $1.06B, beating the average analysts forecast of $1.05B by 1.02%. Apple's EBITDA was $106.56M, beating the average prediction of $87.35M by 21.99%. The company's net income was $62.52M, missing the average estimation of $63.06M by -0.86%. Apple's SG&A was $234.79M, beating the average forecast of $232.25M by 1.10%. Lastly, the company's EPS was $3.83, missing the average prediction of $4.14 by -7.49%. In terms of the last quarterly report (Dec 2023), Addus HomeCare's revenue was $276.35M, beating the average analysts' forecast of $274.47M by 0.69%. The company's EBITDA was $33.02M, beating the average prediction of $23.66M by 39.52%. Addus HomeCare's net income was $19.58M, beating the average estimation of $19.34M by 1.23%. The company's SG&A was $60.77M, beating the average forecast of $60.04M by 1.21%. Lastly, the company's EPS was $1.2, beating the average prediction of $1.17 by 2.36%